Gotoh M - Search Results

1

Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study).

Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Okitsu A, Hamada T, Kobayashi A, Kuroishi K. Yamaguchi O, et al. Among authors: gotoh m. BJU Int. 2015 Oct;116(4):612-22. doi: 10.1111/bju.13068. Epub 2015 Apr 23. BJU Int. 2015. PMID: 25639296 Clinical Trial.

2

Predictability of conventional tests for the assessment of bladder outlet obstruction in benign prostatic hyperplasia.

Homma Y, Gotoh M, Takei M, Kawabe K, Yamaguchi T. Homma Y, et al. Among authors: gotoh m. Int J Urol. 1998 Jan;5(1):61-6. doi: 10.1111/j.1442-2042.1998.tb00238.x. Int J Urol. 1998. PMID: 9535603 Free article.

3

Voiding and incontinence frequencies: variability of diary data and required diary length.

Homma Y, Ando T, Yoshida M, Kageyama S, Takei M, Kimoto K, Ishizuka O, Gotoh M, Hashimoto T. Homma Y, et al. Among authors: gotoh m. Neurourol Urodyn. 2002;21(3):204-9. doi: 10.1002/nau.10016. Neurourol Urodyn. 2002. PMID: 11948713

4

Managing patients with an overactive bladder and glaucoma: a questionnaire survey of Japanese urologists on the use of anticholinergics.

Kato K, Yoshida K, Suzuki K, Murase T, Gotoh M. Kato K, et al. Among authors: gotoh m. BJU Int. 2005 Jan;95(1):98-101. doi: 10.1111/j.1464-410X.2004.05259.x. BJU Int. 2005. PMID: 15638904

5

Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: a randomized controlled trial.

Gotoh M, Kamihira O, Kinukawa T, Ono Y, Ohshima S, Origasa H; Tokai Urological Clinical Trial Group. Gotoh M, et al. BJU Int. 2005 Sep;96(4):581-6. doi: 10.1111/j.1464-410X.2005.05688.x. BJU Int. 2005. PMID: 16104914 Clinical Trial.

6

Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score.

Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Yamanishi T, Yamaguchi O, Takeda M, Nishizawa O. Homma Y, et al. Among authors: gotoh m. Urology. 2006 Aug;68(2):318-23. doi: 10.1016/j.urology.2006.02.042. Urology. 2006. PMID: 16904444

7

Overactive bladder and glaucoma: a survey at outpatient clinics in Japan.

Kato K, Furuhashi K, Suzuki K, Murase T, Sato E, Gotoh M. Kato K, et al. Among authors: gotoh m. Int J Urol. 2007 Jul;14(7):595-7. doi: 10.1111/j.1442-2042.2007.01791.x. Int J Urol. 2007. PMID: 17645600

8

Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder.

Yamaguchi O, Marui E, Kakizaki H, Itoh N, Yokota T, Okada H, Ishizuka O, Ozono S, Gotoh M, Sugiyama T, Seki N, Yoshida M; Japanese Solifenacin Study Group. Yamaguchi O, et al. Among authors: gotoh m. BJU Int. 2007 Sep;100(3):579-87. doi: 10.1111/j.1464-410X.2007.07031.x. BJU Int. 2007. PMID: 17669143 Clinical Trial.

9

Core Lower Urinary Tract Symptom score (CLSS) questionnaire: a reliable tool in the overall assessment of lower urinary tract symptoms.

Homma Y, Yoshida M, Yamanishi T, Gotoh M. Homma Y, et al. Among authors: gotoh m. Int J Urol. 2008 Sep;15(9):816-20. doi: 10.1111/j.1442-2042.2008.02121.x. Epub 2008 Jul 16. Int J Urol. 2008. PMID: 18657204

10

Guidelines for management of urinary incontinence.

Nishizawa O, Ishizuka O, Okamura K, Gotoh M, Hasegawa T, Hirao Y. Nishizawa O, et al. Among authors: gotoh m. Int J Urol. 2008 Oct;15(10):857-74. doi: 10.1111/j.1442-2042.2008.02117.x. Int J Urol. 2008. PMID: 19138285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,504 results

Search Page

Filters